chartexchange
EDTUTC-4 New York
Sign up
FeedbackDocs

IBRX261127C00009500
IBRX Nov 27 2026 9.50 Call
optionOPRA

EODOct 16, 2026
1.20USD-41.463%(-0.85)12Vol20OI
Loading…
Underlying
IBRX
Underlying Price
$8.48
Type
Call
Strike
9.5
Expiration
Nov 27, 2026
DTE
38d
Moneyness
OTM
Intrinsic
$0.00
IBRX 9.5 Call Across Expirations
ExpirationDTELastChangeVolOpen Int
Oct 23, 20263d$0.28-65.00%263438
Oct 30, 202610d$1.24+1.64%8114
Nov 6, 202617d$0.70-48.91%2235
Nov 13, 202624d$0.88-39.73%214221
Nov 27, 202638d$1.20-41.46%1220
IBRX Nearby Strikes · Nov 27, 2026
StrikeLastChangeVolOpen IntMoneyness
6.5 C——00ITM
7 C——00ITM
7.5 C$3.08+0.00%3030ITM
8 C$1.90-25.49%211ITM
8.5 C——00OTM
9 C$1.86+0.00%1010OTM
9.5 C$1.20-41.46%1220OTM
10 C$1.00-31.03%386OTM
10.5 C$0.85-39.29%6103OTM
11 C$1.02+27.50%66OTM
11.5 C——00OTM
12 C$0.85-6.59%23OTM
12.5 C——00OTM
IBRX Profile

immunitybio is a leading registration-stage immuno-oncology and infectious disease company activating both the innate (natural killer cell and macrophage) and adaptive (t cell) immune system. we are developing molecular and product platforms including n-803, aldoxorubicin, and a second-generation adenovirus vector, which are based upon our three key modalities of activating natural killer ('nk') and t cells, tumoricidal macrophages, and memory t cells.